Botulinum Toxin Injection for Laryngeal Disorders
Publisher
Springer Singapore
Reference23 articles.
1. Blitzer A. Spasmodic dysphonia and botulinum toxin: experience from the largest treatment series. Eur J Neurol. 2010;17(Suppl 1):28–30. https://doi.org/10.1111/j.1468-1331.2010.03047.x.
2. Ludlow CL, Adler CH, Berke GS, et al. Research priorities in spasmodic dysphonia. Otolaryngol Head Neck Surg. 2008;139(4):495–505. https://doi.org/10.1016/j.otohns.2008.05.624.
3. Sapienza CM, Walton S, Murry T. Adductor spasmodic dysphonia and muscular tension dysphonia: acoustic analysis of sustained phonation and reading. J Voice. 2000;14(4):502–20. https://doi.org/10.1016/s0892-1997(00)80008-9.
4. Roy N, Mazin A, Awan SN. Automated acoustic analysis of task dependency in adductor spasmodic dysphonia versus muscle tension dysphonia. Laryngoscope. 2014;124(3):718–24. https://doi.org/10.1002/lary.24362.
5. Troung DD, Rontal M, Rolnick M, et al. Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia. Laryngoscope. 1991;101(6 Pt 1):630–4. https://doi.org/10.1288/00005537-199106000-00010.